Clinical Trial Update: Neurotoxicity of Spinal Anesthesia With Ropivacaine and Bupivacaine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating neurotoxicity associated with spinal anesthesia using ropivacaine and bupivacaine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia-related Adverse Effects
• Spinal and Epidural Anesthesia Complications

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Ropivacaine (Ropivacaine)

Snippet

Sponsor: University of Rzeszow | Conditions: Anesthesia; Adverse Effect, Spinal and Epidural, Anaesthetic Complication Neurological | Phase 4 | Status: UNKNOWN